267 related articles for article (PubMed ID: 865134)
1. Agreement among three different indices of sympathetic nervous system activity in essential hypertension.
Esler M; Zweifler A; Randall O; Julius S; DeQuattro V
Mayo Clin Proc; 1977 Jun; 52(6):379-82. PubMed ID: 865134
[TBL] [Abstract][Full Text] [Related]
2. Mild high-renin essential hypertension. Neurogenic human hypertension?
Esler M; Julius S; Zweifler A; Randall O; Harburg E; Gardiner H; DeQuattro V
N Engl J Med; 1977 Feb; 296(8):405-11. PubMed ID: 834210
[TBL] [Abstract][Full Text] [Related]
3. High-renin essential hypertension: adrenergic cardiovascular correlates.
Esler M; Julius S; Randall O; DeQuattro V; Zweifler A
Clin Sci Mol Med Suppl; 1976 Dec; 3():181s-184s. PubMed ID: 1071602
[TBL] [Abstract][Full Text] [Related]
4. [Labile arterial hypertension and sympathetic tonus. Hemodynamic study].
Simon A; Lehner JP; Safar M; Alexandre JM; Weiss Y; Milliez P
Arch Mal Coeur Vaiss; 1976 Dec; 69(12):1305-9. PubMed ID: 827268
[TBL] [Abstract][Full Text] [Related]
5. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
Ibsen H; Julius S
Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of autonomic nervous control in borderline hypertension.
Julius S
Schweiz Med Wochenschr; 1976 Dec; 106(49):1698-705. PubMed ID: 1013692
[TBL] [Abstract][Full Text] [Related]
9. Effects of propranolol on cardiovascular and neurohumoral actions of alcohol in hypertensive patients.
Kawano Y; Abe H; Kojima S; Takishita S; Omae T
Blood Press; 1999; 8(1):37-42. PubMed ID: 10412881
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of propranolol in hypertension: a review.
Tarazi RC; Dustan HP; Bravo EL
Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
13. Studies on the activity of the sympathetic nervous system in essential hypertension.
Chobanian AV; Garvras H; Gavras I; Bresnahan M; Sullivan P; Melby JC
J Human Stress; 1978 Sep; 4(3):22-8. PubMed ID: 690418
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise.
Hansen JF; Hesse B; Christensen NJ
Eur J Clin Invest; 1978 Feb; 8(1):31-6. PubMed ID: 417929
[TBL] [Abstract][Full Text] [Related]
15. The sympathetic nervous system in the pathogenesis of hypertension.
Rahn KH; Barenbrock M; Hausberg M
J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
[TBL] [Abstract][Full Text] [Related]
16. [Significance of sympathetic nerve activity in the pathogenesis of essential hypertension, with special reference to the effects of centrally-acting sympatholytics on plasma norepinephrine concentration and hemodynamic variables].
Tomioka H; Miura Y; Adachi M; Kimura S; Nezu M; Yoshinaga K
Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1103-13. PubMed ID: 7175313
[No Abstract] [Full Text] [Related]
17. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
Mookherjee S; Eich RH; Obeid AI; Smulyan H
Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
[TBL] [Abstract][Full Text] [Related]
18. [Systemic arterial hypertension: pathogentic role of the sympathetic nervous system].
Andrejak M; Simon A; Hardin JM; Fournier A; Safar M; Quichaud J
Nouv Presse Med; 1977 Dec; 6(42):3963-7. PubMed ID: 600739
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and determinants of elevated plasma norepinephrine concentration in compensated cirrhosis.
Rector WG; Robertson AD
Am J Gastroenterol; 1994 Nov; 89(11):2049-53. PubMed ID: 7942734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
